Duloxetine: Lilly Receives Approvable Letter - News on FDA action in September 2002 related to the dual 5HT/noradrenaline reuptake inhibitor (also known as Cymbalta) for the treatment of depression. - http://www.ims-global.com/insight/drugs_news/0209/drug_news_020927.htm